Article

PDF
Access to the PDF text
Advertising



Archives of cardiovascular diseases
Volume 112, n° 3
pages 162-170 (mars 2019)
Doi : 10.1016/j.acvd.2018.10.003
Received : 15 May 2018 ;  accepted : 4 October 2018
Cliical research

Evolution of chronic kidney disease after surgical aortic valve replacement or transcatheter aortic valve implantation
Évolution des patients insuffisants rénaux chroniques après un remplacement valvulaire aortique chirurgical ou percutané
 

Figure 1




Figure 1 : 

Evolution of estimated glomerular filtration rate (eGFR) 1 year after the procedure, compared with baseline eGFR. SAVR: surgical aortic valve replacement; TAVI: transaortic valve implantation.


Figure 2




Figure 2 : 

Evolution of estimated glomerular filtration rate (eGFR) from the preprocedural period to the last follow-up for each patient according to chronic kidney disease stages 3b and 4–5 in the surgical aortic valve replacement (SAVR) group (n =49) and the transaortic valve implantation (TAVI) group (n =57).

EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline